These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8577818)

  • 1. Stimulating activity of A-4166 on insulin release in in situ hamster pancreatic perfusion.
    Seto Y; Fujita H; Dan K; Fujita T; Kato R
    Pharmacology; 1995 Oct; 51(4):245-53. PubMed ID: 8577818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of D-phenylalanine-derivative hypoglycemic agent A-4166 on pancreatic alpha- and beta-cells: comparative study with glibenclamide.
    Hirose H; Maruyama H; Seto Y; Ito K; Fujita T; Dan K; Kanda N; Saruta T; Kato R
    Pharmacology; 1995 Mar; 50(3):175-81. PubMed ID: 7746834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas.
    Fujitani S; Ikenoue T; Akiyoshi M; Maki T; Yada T
    Metabolism; 1996 Feb; 45(2):184-9. PubMed ID: 8596487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin secretion from isolated rat islets induced by the novel hypoglycemic agent A-4166, a derivative of D-phenylalanine.
    Tsukuda K; Sakurada M; Niki I; Oka Y; Kikuchi M
    Horm Metab Res; 1998 Jan; 30(1):42-9. PubMed ID: 9503038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel D-phenylalanine-derivative hypoglycemic agent A-4166 increases cytosolic free Ca2+ in rat pancreatic beta-cells by stimulating Ca2+ influx.
    Fujitani S; Yada T
    Endocrinology; 1994 Mar; 134(3):1395-400. PubMed ID: 8119179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166).
    Ikenoue T; Akiyoshi M; Fujitani S; Okazaki K; Kondo N; Maki T
    Br J Pharmacol; 1997 Jan; 120(1):137-45. PubMed ID: 9117089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
    Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
    J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glibenclamide but not other sulphonylureas stimulates release of neuropeptide Y from perifused rat islets and hamster insulinoma cells.
    Kulkarni RN; Wang ZL; Wang RM; Smith DM; Ghatei MA; Bloom SR
    J Endocrinol; 2000 May; 165(2):509-18. PubMed ID: 10810315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
    Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
    Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics, insulinotropic action and hypoglycemic effect of nateglinide and glibenclamide in normal and diabetic rats.
    Courtois P; Jijakli H; Ladriere L; Oguzhan B; Sener A; Malaisse WJ
    Int J Mol Med; 2003 Jan; 11(1):105-9. PubMed ID: 12469228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine], on postprandial blood glucose excursion: comparison with voglibose and glibenclamide.
    Ikenoue T; Okazaki K; Fujitani S; Tsuchiya Y; Akiyoshi M; Maki T; Kondo N
    Biol Pharm Bull; 1997 Apr; 20(4):354-9. PubMed ID: 9145209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of insulinotrophic actions of nateglinide with glibenclamide dissociated from absorption in conscious dogs.
    Okamoto M; Ogihara N; Kawamura W; Ebihara S; Takiguchi K; Morita T; Uchida R; Yamaguchi J; Sakai T; Okuda Y; Hayashi Y; Arakawa Y; Kikuchi M
    Metabolism; 2002 May; 51(5):575-81. PubMed ID: 11979388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide.
    Garrino MG; Schmeer W; Nenquin M; Meissner HP; Henquin JC
    Diabetologia; 1985 Sep; 28(9):697-703. PubMed ID: 3934021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of glibenclamide and nateglinide upon pancreatic islet function in normal and diabetic rats.
    Laghmich A; Ladrière L; Malaisse-Lagae F; Malaisse WJ
    Pharmacol Res; 1999 Dec; 40(6):475-82. PubMed ID: 10660944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.
    Fuhlendorff J; Rorsman P; Kofod H; Brand CL; Rolin B; MacKay P; Shymko R; Carr RD
    Diabetes; 1998 Mar; 47(3):345-51. PubMed ID: 9519738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired glucose-stimulated insulin secretion and reduced β-cell mass in pancreatic islets of hyperthyroid rats.
    Karbalaei N; Noorafshan A; Hoshmandi E
    Exp Physiol; 2016 Aug; 101(8):1114-27. PubMed ID: 27060234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166) on insulin and glucagon secretion in isolated perfused rat pancreas.
    Hirose H; Maruyama H; Ito K; Seto Y; Kido K; Koyama K; Dan K; Saruta T; Kato R
    Pharmacology; 1994 Apr; 48(4):205-10. PubMed ID: 8177906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in therapy for diabetes mellitus--insulin-secretion inducing oral hypoglycemic agents].
    Nagashima K; Inagaki N
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):737-41. PubMed ID: 19472523
    [No Abstract]   [Full Text] [Related]  

  • 19. Involvement of amlodipine, diazoxide, and glibenclamide in development of morphine tolerance in mice.
    Khalilzadeh O; Anvari M; Khalilzadeh A; Sahebgharani M; Zarrindast MR
    Int J Neurosci; 2008 Apr; 118(4):503-18. PubMed ID: 18322859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of insulin secretion following long-term manipulation of ATP-sensitive potassium channels by diazoxide and nateglinide.
    Ball AJ; Flatt PR; McClenaghan NH
    Biochem Pharmacol; 2005 Jan; 69(1):59-63. PubMed ID: 15588714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.